SCNX supply chain intelligence for Scienture Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| EXCHANGE-HEALTH | EXCHANGE-HEALTH | 90% | The Company entered into a relationship with Exchange Health, LLC, a technology company providing an online platform for manufacturers and suppliers to sell and purchase pharmaceuticals |
| TOLLO-HEALTH-LLC | TOLLO-HEALTH-LLC | 85% | the Company agreed to sell all of the |
| RAINFOREST | RAINFOREST | 80% | Superlatus PD Holding Company, Inc., a purported subsidiary of Superlatus, entered into a supplier agreement with Rainforest, pursuant to which Superlatus allegedly appointed Rainforest as its exclus… |
| RAINFOREST-DISTRIBUTION-CORP | RAINFOREST-DISTRIBUTION-CORP | 80% | Superlatus PD Holding Company, Inc., a purported subsidiary of Superlatus, entered into a supplier agreement with Rainforest Distribution Corp, a New York corporation, pursuant to which Superlatus al… |
| ORANY | ORANY | 72% | supplements to approved applications; ● require revisions to the labeling, including limitations on approved uses or the addition of additional warnings, contraindications or other safety information… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from SCNX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from SCNX graph: supplements to approved applicati… |
| WGRX | Wellgistics Health, Inc. | 72% | Reciprocal relationship from WGRX graph: Reciprocal relationship from SCNX graph: Reciprocal relationship from WGRX graph: Reciprocal relationship from SCNX graph: Reciprocal relationship from WGRX g… |
| ANTHEM | ANTHEM | 70% | Anthem will only allow those employees and personnel under Anthem's direct control to perform such services and will obtain Scienture LLC's consent prior to delegating or subcontracting any portion o… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ALLIANCE-PHARMA-SOLUTIONS | ALLIANCE-PHARMA-SOLUTIONS | 85% | the Company entered into Membership Interest Purchase Agreements to sell 100% of the outstanding membership interests of the Company's former subsidiaries, Alliance Pharma Solutions, LLC |
| ALLIANCE-PHARMA-SOLUTIONS-LLC | ALLIANCE-PHARMA-SOLUTIONS-LLC | 85% | On January 20, 2023, the Company entered into Membership Interest Purchase Agreements to sell 100% of the outstanding membership interests of the Company's former subsidiaries, Alliance Pharma Soluti… |
| COMMUNITY-SPECIALTY-PHARMACY | COMMUNITY-SPECIALTY-PHARMACY | 85% | the Company entered into Membership Interest Purchase Agreements to sell 100% of the outstanding membership interests of the Company's former subsidiaries, Community Specialty Pharmacy, LLC |
| COMMUNITY-SPECIALTY-PHARMACY-LLC | COMMUNITY-SPECIALTY-PHARMACY-LLC | 85% | On January 20, 2023, the Company entered into Membership Interest Purchase Agreements to sell 100% of the outstanding membership interests of the Company's former subsidiaries, Community Specialty Ph… |
| SUPERLATUS-INC | SUPERLATUS-INC | 85% | the Company entered into an Amended and Restated Agreement and Plan of Merger with Superlatus Inc |
| ORANY | ORANY | 72% | supplements to approved applications; ● require revisions to the labeling, including limitations on approved uses or the addition of additional warnings, contraindications or other safety information… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from SCNX graph: supplements to approved applications; ● require revisions to the labeling, including limitations on approved uses or… |
| WGRX | Wellgistics Health, Inc. | 72% | Reciprocal relationship from WGRX graph: Reciprocal relationship from SCNX graph: erience, and other currently available evidence. Other Receivables As of December 31, 2024 and 2023, other receivable… |
| WGRX | Wellgistics Health, Inc. | 72% | erience, and other currently available evidence. Other Receivables As of December 31, 2024 and 2023, other receivables are $ and $ . As of December 31, 2024, other receivables primarily consist of sh… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| SCNX-DEBT | Debt stack $24,137 | 90% | Market cache reports total debt of $24,137. |
| SCNX-DEBT-12422 | Warrants outstanding: 238594 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| SCNX-DEBT-12423 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| SCNX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 90% | 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 14 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| WGRX | Wellgistics Health, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ORANY | ORANGE | 100.00 | 1 | ['customer', 'supplier'] |
| AMZE | Amaze Holdings, Inc. | 50.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 50.00 | 2 | |
| AYTU | Aytu BioPharma, Inc. | 50.00 | 2 | |
| D | Dominion Energy, Inc. | 50.00 | 2 | |
| CANF | Can-Fite BioPharma Ltd. | 50.00 | 2 | |
| ESS | Essex Property Trust, Inc. | 50.00 | 2 | |
| DFTX | Definium Therapeutics, Inc. | 50.00 | 2 | |
| CHUC | Charlie's Holdings, Inc. | 50.00 | 2 | |
| CLNE | Clean Energy Fuels Corp. | 50.00 | 2 | |
| FENC | Fennec Pharmaceuticals Inc. | 50.00 | 2 | |
| EQR | Equity Residential | 50.00 | 2 | |
| CNOB | ConnectOne Bancorp, Inc. | 50.00 | 2 | |
| DWTX | Dogwood Therapeutics, Inc. | 50.00 | 2 | |
| DARE | Daré Bioscience, Inc. | 50.00 | 2 | |
| ED | Consolidated Edison, Inc. | 50.00 | 2 | |
| CORT | Corcept Therapeutics Incorporated | 50.00 | 2 | |
| BSBK | Bogota Financial Corp. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 |